OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAD8. A total of 28 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$36,888,000,000
+0.7%
41,000,000
-9.9%
0.94%
+15.8%
Q2 2020$36,628,000,000
+5.8%
45,500,0000.0%0.81%
+13.5%
Q1 2020$34,617,000,000
+34.8%
45,500,000
+46.8%
0.71%
-1.9%
Q4 2019$25,688,000,000
+3.4%
31,000,000
+3.3%
0.73%
+5.2%
Q3 2019$24,845,000,000
+4.2%
30,000,0000.0%0.69%
+49.6%
Q2 2019$23,854,000,000
+24.9%
30,000,000
+62.2%
0.46%
+25.5%
Q1 2018$19,101,000,000
-28.8%
18,500,000
-40.3%
0.37%
-22.5%
Q4 2017$26,837,000,000
+451.7%
31,000,000
+520.0%
0.48%
+569.0%
Q3 2017$4,864,000,0005,000,0000.07%
Other shareholders

There were no reported owners of AMAG PHARMACEUTICALS INC in Q2 2018.

NameSharesValueWeighting ↓
View complete list of AMAG PHARMACEUTICALS INC shareholders